Zurich consensus: German expert opinion on the st. gallen votes on 15 march 2009 (11th international conference at St. Gallen: Primary therapy of early breast cancer);St.-Gallen-Konferenz 2009 zum primären Mammakarzinom

Geburtshilfe und Frauenheilkunde

Volumn 69, Issue 5, 2009, Pages 377-383

  Beckmann, M W ^a   Blohmer, J U ^b   Costa, S D ^c   Diedrich, K ^d   Diel, I ^e   Eiermann, W ^f   Friese, K ^g   Gerber, B ^h   Harbeck, N ⁱ   Hilfrich, J ^j   Janni, W ^k   Janicke F ^l   Jonat, W ^m   Kaufmann, M ⁿ   Kiechle, M ^o   Kohler U ^p   Kreienberg, R ^q   Von Minckwitz, G ^r   Mobus V ^s   Nitz, U ^t   Schneeweiss, A ^u   Thomssen, C ^v   Wallwiener, D ^w   more..

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e Gemeinschaftspraxis Gynäkologie und Geburtshilfe   (Germany)

^f Rotkreuzklinikum München   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h Universitatsfrauenklinik Rostock   (Germany)

ⁱ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^j Eilenriedeklinik   (Germany)

^k UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^l UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^m UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁿ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^o TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^p Klinikum St Georg   (Germany)

^q UNIVERSITY HOSPITAL ULM   (Germany)

^r German Breast Group   (Germany)

^s Frauenklinik Am Klinikum Höchst   (United States)

^t Bethesda Monchengladbach GmbH   (Germany)

^u UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^v MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^w UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

more..

Author keywords

German experts; Primary breast cancer; St. Gallen Consensus 2009

Indexed keywords

AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CLODRONIC ACID; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2D6; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB; ZOLEDRONIC ACID;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER GRADING; CLINICAL DECISION MAKING; CONFERENCE PAPER; CONSENSUS; GENE OVEREXPRESSION; GERMANY; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; MEDICAL RESEARCH; POSTMENOPAUSE; PROGNOSIS; SYSTEMIC THERAPY; TREATMENT INDICATION;

EID: 77149122435     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0029-1185651     Document Type: Conference Paper

References (13)

1. Wolfe et al. JCO 2007
2. von Minckwitz et al. SABCS 2008, Abstract
3. Dunne et al. JCO 2009
4. Peto et al. NEJM 2005
5. EBCTCG. Lancet 2005
6. Andre et al. 2008
7. Hayes et al. NEJM 2007
8. Martin et al. NEJM 2005
9. Martin et al. ASCO 2008, Abstract
10. Möbus et al. SABCS 2006, Abstract
11. Citron et al. JCO 2003
12. Slamon et al. SABCS 2006, Abstract
13. Jones et al. JCO 2009